Armistice Capital, LLC 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 11:24 am Sale | 2026-03-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | Armistice Capital, LLC | 15,028,000 9.220% | -997,000 (-6.22%) | Filing |
| 2026-02-17 9:45 pm Sale | 2025-12-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | Armistice Capital, LLC | 16,025,000 9.850% | -125,000 (-0.77%) | Filing |
| 2025-05-15 3:29 pm Purchase | 2025-03-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | Armistice Capital, LLC | 13,700,000 8.470% | 4,232,000 (+44.70%) | Filing |
| 2025-02-14 5:49 pm Purchase | 2024-12-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | Armistice Capital, LLC | 9,468,000 5.920% | 1,268,000 (+15.46%) | Filing |
| 2024-11-14 3:31 pm Purchase | 2024-09-30 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | Armistice Capital, LLC | 8,200,000 5.130% | 8,200,000 (New Position) | Filing |